IDSA's Secrets:

Bioweapon Attributes Dickson FDA Yale USDOJ RICO

PubMed: TLR2

"New World Disorder"
IDSA's Persistence "Cryme Disease" book Klempner's Fraud RICO Patents Osp-A/Viral Synergy Grants Search "TLR2" Kissinger NWO Beast
Relapsing Fever Dearborn Quotes Plum Island Corixa RICO "LYMErix ▲ Disease" Myco & Erythrocytes Rx Brain Damage
Steere Falsifies Test Dearborn Booklet Russians & NYMC CDCs Patents w/SKB GarthNicolson-GWI Rockefeller/Psychiatry
IDSA's Imitators Schoen-LYMErix IDSA: "Cyst Viable" DARPA Boots CDC Confronting Crooked NIH CT Med Board Hell/NDEs
IDSA's ShellGame Weinstein's Frauds LYMErix ►Imitators Auwaerter Epstein-Barr NIH Disinfo Foreign CPS' Sexual Assaults
IDSA's Biomarkers Yale's Valid Test UConn's KidTuskegee Plum Stupid Vaccines' Brain Damage Fraud With Intent   CPS' Entrapment
IDSA's Stupid Rx
 
Not used ▲to assess LYMErix? Yale's Congen Lyme
 
IDSA ▲ self-indicts
 

 
Update on Sex Abuse
 


24 May 2012 

HOME


Natural Remedies
 

CDC writes a "bogus article" on Mycoplasma in the blood and Chronic Fatigue.
 

Lyme/LYMErix Cryme Reveals  New Paradigm in Health/Disease:
"Bacterial/Viral Coinfections";

TLR2 (fungi)Signaling Depletes IRAK1 and Inhibits Induction of Type 1 by TLR7/9  (viruses)-- 
-CV Harding, 2012  (More in the chart at the bottom of this homepage)

CFIDS = Seronegative Chronic Active EBV

"Multiple Mechanisms of Immune Suppression by B Lymphocytes" (New and Trashes Yale and IDSA)

NIH's Treatment Recommendations for Chronic Active Epstein-Borreliosis, the chronic illness also induced by OspA vaccination or exposure to molds.

The Antics of the Crazy Stalker Durland Fish and the New Genre in "Education."
 


CDC Greed (won't answer the FOIA)

ELISA = arbitrary cutoff.

Disclaimer

Overview


TUSKEGEE - By Jerry Leonard


1998, CIA Oilmen & Israelis plan to overthrow Saddam for the oil.

Bush/Gore  Oil/War-(Oct,2000)  

Bush's own explainer (Oct 2000) re: Iraq Oil




 

 

FROM THE 2003 ACTIONLYME.com WEBSITE:

 

1) rOspA vaccination was not demonstrated to protect monkeys from infection:

The outer surface protein A (OspA) vaccine against Lyme disease: efficacy in the rhesus monkey.
Philipp MT, Lobet Y, Bohm RP Jr, Roberts ED, Dennis VA, Gu Y, Lowrie RC Jr, Desmons P, Duray PH, England JD, Hauser P, Piesman J, Xu K.
Vaccine. 1997 Dec;15(17-18):1872-87.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9413097&dopt=Abstract

 

2) rOspA vaccination did not protect rabbits:

Comparison of protection in rabbits against host-adapted and cultivated Borrelia burgdorferi following infection-derived immunity or immunization with outer membrane vesicles or outer surface protein A.

Shang ES, Champion CI, Wu XY, Skare JT, Blanco DR, Miller JN, Lovett MA.

Department of Microbiology and Immunology, Department of Medicine, School of Medicine, University of California, Los Angeles, California 90095, USA.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10858236&dopt=Abstract

"Analysis of the antibody responses to outer membrane proteins, including DbpA, OspA, and OspC, suggests that the remarkable protection exhibited by the infection-immune rabbits is due to antibodies directed at antigens unique to or markedly up-regulated in host-adapted B. burgdorferi." 

 

3) rOspA was not shown to protect mice, and why, by Russell Johnson:

Resistance to tick-borne spirochete challenge induced by Borrelia burgdorferi strains that differ in expression of outer surface proteins.

Kurtti TJ, Munderloh UG, Hughes CA, Engstrom SM, Johnson RC.
Infect Immun. 1996 Oct;64(10):4148-53

There was no reduction of strain 297 spirochetes in ticks that fed on four hamsters immunized with M297, but the hamsters were protected.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8926082&dopt=Abstract

The journal publications of Russell Johnson-->  MEDLINE:  "Johnson RC [au] and spirochete"

 

 

4) rOspA vaccination results in escape mutants or variants spirochetes which INCREASE at a greater rate than normal.

Selection of variant Borrelia burgdorferi isolates from mice immunized with outer surface protein A or B.
Fikrig E, Tao H, Barthold SW, Flavell RA.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7729870&dopt=Abstract

 

Experiments in vitro in which complement is added demonstrate the antibodies to rOspA alone do not kill the spirochetes:

Borrelia burgdorferi escape mutants that survive in the presence of antiserum to the OspA vaccine are killed when complement is also present.
Sole M, Bantar C, Indest K, Gu Y, Ramamoorthy R, Coughlin R, Philipp MT.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9596714&dopt=Abstract

 

5) Yale did not demonstrate that there were not spirochetes in the ticks after vaccination and then feeding ticks on animal blood, then assaying for spirochetes:

 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1608951&dopt=Abstract

Elimination of Borrelia burgdorferi from vector ticks feeding on OspA-immunized mice. 
Fikrig E, Telford SR 3rd, Barthold SW, Kantor FS, Spielman A, Flavell RA.
Proc Natl Acad Sci U S A. 1992 Jun 15;89(12):5418-21.
 

They used the wrong fluorescing antibodies and they did not use any DNA method, like their own patented DNA, US 5,618,533.  This was a completely bogus article.